ADRs of CSL Limited (OTCQX:CSLLY) dropped ~16% on Tuesday as Wall Street reacted to Australian biotech’s plans to lay off 15% of its workforce, announced in conjunction with its fiscal 2025 financials ...

The modest increase in CSL shares stands out against the backdrop of a declining local market, where the S&P/ASX 200 fell 0.66% to 8,815.9. RBC's decision to upgrade CSL comes after a significant 36% ...

Fintel reports that on December 8, 2025, JEFFERIES maintained coverage of CSL Limited - Depositary Receipt (OTCPK:CSLLY) with a Buy recommendation. As of December 6, 2025, the average one-year price ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from CSL ( (AU:CSL)) is ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. CSL ( (AU:CSL)) has issued an ...

CSL Limited has informed the market that 34,261 conditional rights (security code CSLAL) have lapsed after the performance or vesting conditions attached to them were not satisfied or became incapable ...

CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than $500 million per year over the next ...

Australian biotechnology firm CSL Ltd (OTCQX:CSLLY) (OTCQX:CMXHF) is set to downsize its research and development (R&D) division across six international sites, and increase its reliance on external ...